申请人:SCHERING CORP
公开号:WO2006002133A1
公开(公告)日:2006-01-05
Compounds of Formula (I) and/or pharmaceutically acceptable salts, solvates or prodrugs thereof, or pharmaceutical compositions containing such compounds exhibit anti-inflammatory and immunomodulatory activity, and can be effective asCB2 receptor ligands in treating cancer and inflammatory, immunomodulatory or respiratory diseases or conditions.
化合物式(I)及/或其药学上可接受的盐、溶剂或前药,或含有这些化合物的药物组合物表现出抗炎和免疫调节活性,并且在治疗癌症和炎症、免疫调节或呼吸系统疾病或症状中可以作为CB2受体配体而发挥作用。